Evidence map›Paper›PMID 39956593›Full record

Trial reportBMJ open2025

A qualitative enquiry into participants' and practitioners' experiences in the Australian Liver FaIlurE trial.

Jeyamani Ramachandran, Anuradha Pati, Luisa Wigg, Sumudu K Narayana, Sharon Lawn, Kate Muller, Alan J Wigg

Abstract readRandomized Controlled TrialMulticenter Study
In one paragraph

Trial report in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jeyamani RamachandranHepatology and Liver Transplantation Medicine Unit, Flinders Medical Centre, Bedford Park, South Australia, Australia jeyamani.ramachandran@sa.gov.au.ORCID http://orcid.org/0000-0002-2505-9274
Anuradha PatiThe University of Adelaide-North Terrace Campus, Adelaide, South Australia, Australia.
Luisa WiggJames Cook University-Townsville City Campus, Townsville, Queensland, Australia.
Sumudu K NarayanaHepatology and Liver Transplantation Medicine Unit, Flinders Medical Centre, Bedford Park, South Australia, Australia.
Sharon LawnCollege of Medicine and Public Health, Flinders University, Bedford Park, South Australia, Australia.ORCID http://orcid.org/0000-0002-5464-8887
Kate MullerHepatology and Liver Transplantation Medicine Unit, Flinders Medical Centre, Bedford Park, South Australia, Australia.
Alan J WiggHepatology and Liver Transplantation Medicine Unit, Flinders Medical Centre, Bedford Park, South Australia, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Australian Liver FaIlurE (ALFIE) trial, a multicentre, randomised controlled trial, assessed the efficacy of a nurse-coordinated model of care to reduce liver-related emergency admissions (LREAs) in patients with decompensated cirrhosis. The model of care was delivered by a specialist nurse, including intensive postdischarge monitoring, linkage to multidisciplinary care, rapid access to care pathway, enhanced education and self-management support.

objectiveTo examine the experiences of participants and practitioners in the ALFIE trial to understand its impact, barriers and areas for improvement. DESIGN AND

settingA qualitative semistructured interview analysis nested within the ALFIE trial.

participantsA purposeful sample of 15 patients, 14 controls and 12 staff.

interventionThematic analysis of interview transcripts.

resultsInterventional participants and the nurses perceived the care provided as personalised, holistic and continuous. The intervention enabled the development of robust therapeutic relationships and trust that promoted participant engagement and risk factor modification. It helped intervention participants navigate the busy hospital system. The control participants desired more education and a personal contact to deal with emergencies. With respect to the intervention, nurses felt that their support helped reduce LREAs and improve care, but it was overwhelming. A number of barriers and systemic issues were identified. Suggestions for improvement of the intervention model included increased staffing, improved mental health support and communication pathways with primary care practitioners.

conclusionsThe ALFIE trial was well received by nurses and participants. It met the needs of intervention participants and the health system through easy-to-navigate, personalised, holistic and ongoing care. The study identified barriers and systemic improvement areas. TRIAL REGISTRATION NUMBER: ACTRN12617001293358.

Indexed as

Attitude of Health PersonnelLiver CirrhosisLiver FailureAdultAgedAustraliaFemaleHumansInterviews as TopicMaleMiddle AgedQualitative ResearchClinical TrialHealth policyHealth Services

Identifiers

PMID39956593
PMCPMC11831275

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.